Alan  Ehrlich, MD

Alan Ehrlich, MD

Alan Ehrlich, MD, is a deputy editor for DynaMed, a database that provides evidence-based information on more than 3,000 clinical topics and is updated daily through systematic surveillance covering more than 500 journals. He is also an assistant clinical professor in Family Medicine at the University of Massachusetts Medical School in Worcester.

Most Recent Articles by Alan Ehrlich, MD

Emollient Bath Additives Ineffective for Atopic Dermatitis in Children

Emollient Bath Additives Ineffective for Atopic Dermatitis in Children

By

Although the American Academy of Dermatology recommends the direct application of emollients to the skin in patients with atopic dermatitis, the addition of oils, emollients, or other additives to bath water is not recommended due to insufficient evidence regarding their efficacy.

Adjuvant Chemo With Endocrine Therapy for HR+/HER2- Breast Cancer

Adjuvant Chemo With Endocrine Therapy for HR+/HER2- Breast Cancer

By

Although endocrine therapy following surgery is recommended for HR-positive/HER2-negative, axillary node-negative breast cancers, the value of adjuvant chemotherapy in the setting of moderate risk is unclear.

Budesonide/Formoterol for the Prevention of Serious Asthma Exacerbations

Budesonide/Formoterol for the Prevention of Serious Asthma Exacerbations

By

The SYGMA trials assessed the use of an as-needed combined corticosteroid/beta-agonist inhaler in patients with mild asthma.

Limited Formula Supplementation May Not Adversely Affect Breastfeeding

Limited Formula Supplementation May Not Adversely Affect Breastfeeding

By

Although exclusive breastfeeding for the first 6 months of life is recommended by several health organizations, there may be a delay before abundant maternal milk production is established.

Regular proton pump inhibitor use associated with an increased risk of dementia in the elderly

Regular proton pump inhibitor use associated with an increased risk of dementia in the elderly

By

Regular proton pump inhibitor use in the elderly was associated with an increased risk of incident dementia compared with no proton pump inhibitor use, according to researchers.

More Articles by Alan Ehrlich, MD

Sign Up for Free e-newsletters